BiVictriX Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $2,860,000.
Profit Margin
| 2018 | 0 | -378K | |
|---|---|---|---|
| 2019 | 0 | -409K | |
| 2020 | 0 | -425K | |
| 2021 | 0 | -2.33M | |
| 2022 | 0 | -2.49M | |
| 2023 | 0 | -2.54M |
BVX.L Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 165K | 151K | 46K | 1K | 0 | 0 |
Gross profit | -165K | -151K | -46K | -1K | 0 | 0 |
Operating exp. | ||||||
Research and development | 1.88M | 2.11M | 711K | 305K | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 4K | 0 | 0 |
Total operating expenses | 2.86M | 2.97M | 1.50M | 521K | 526K | 480K |
Operating income | -3.02M | -2.97M | -1.89M | -490K | -526K | -480K |
Other income (expenses), net | 22K | 4K | -641K | -19K | 0 | 0 |
Income before tax | -3.00M | -2.97M | -2.53M | -509K | -526K | -480K |
Income tax expense | -458K | -474K | -193K | -84K | -117K | -102K |
Net income | -2.54M | -2.49M | -2.33M | -425K | -409K | -378K |
Earnings per share | ||||||
Basic EPS | -0.03 | -0.03 | -0.03 | -0.01 | -0.00 | -0.00 |
Diluted EPS | -0.03 | -0.03 | -0.03 | -0.01 | -0.00 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source |